Skip to content

Intelligent diagnosis of pulmonary tuberculosis based on acoustic biomarkers

Intelligent diagnosis of pulmonary tuberculosis based on acoustic biomarkers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111321
Enrollment
Unknown
Registered
2025-10-29
Start date
2025-10-30
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary tuberculosis

Interventions

Gold Standard:Sputum smear or culture positive and Xpert positive
Index test:Intelligent Tuberculosis Diagnosis System Based on Acoustic Features

Sponsors

Beijing Chest Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Healthy controls: Healthy people with no history of smoking and dust exposure, no respiratory symptoms, no suspicious lesions on chest CT, no other active diseases, over 18 years of age, and no drug treatment. Pulmonary tuberculosis group: pulmonary tuberculosis patients with positive molecular biology, positive culture or positive pathology in the Health industry Standard-Pulmonary Tuberculosis Diagnosis (WS288-2017) of the People's Republic of China 1.Patients with active pulmonary tuberculosis who met the diagnostic criteria. 2.Over 18 years old, male or female. 3. informed consent. Other lung disease group: 1.Patients with clinical/confirmed diagnosis of lung cancer, pneumonia, interstitial lung disease, chronic obstructive pulmonary disease, bronchial asthma, bronchiectasis, etc. 2.Over 18 years old, male or female. 3.Informed consent.

Exclusion criteria

Exclusion criteria: Tuberculosis group: 1.Patients with various neuropsychiatric diseases such as disturbance of consciousness, dyslexia and so on, who cannot cough, breathe and make speech actively after training. 2.Severely malnourished patients who are unable to cough actively, breathe deeply and produce speech. 3.Patients with myasthenia gravis or neuromuscular contact. 4.Patients with vocal system injury or maxillofacial major surgery or tumor. 5.Patients with active hemoptysis in the last 2 weeks. 6.Patients with pneumothorax in recent 4 weeks. Other lung disease group: 1. Patients with various neuropsychiatric diseases such as disturbance of consciousness, dyslexia and so on, who cannot cough, breathe and make speech actively after training. 2.Severely malnourished patients who are unable to cough actively, breathe deeply and produce speech. 3.Patients with myasthenia gravis or neuromuscular contact. 4.Patients with vocal system injury or maxillofacial major surgery or tumor. 5.Patients with active hemoptysis in the last 2 weeks. 6.Patients with pneumothorax in recent 4 weeks.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity;

Countries

China

Contacts

Public ContactYang Xinting

Beijing Chest Hospital Affiliated to Capital Medical University

2320652139@qq.com+86 159 1108 6290

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026